RecruitingPhase 2 / Phase 3NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Sponsor: Biohaven Therapeutics Ltd.
Birmingham, AL · Irvine, CA · Los Angeles, CA · +21 more sites